Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1,2:4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate | Patent Publication Number 20180065986

US 20180065986 A1
Patent NumberUS 10385067 B2
Application Number15624166
Filled DateJun 15, 2017
Priority DateJun 20, 2014
Publication DateMar 8, 2018
Original AssigneeGilead Sciences
Current AssigneeGilead Sciences
Inventor/ApplicantsErnest A. Carra
Vahid Zia
Irene Chen
ERNEST A. CARRA
VAHID ZIA
IRENE CHEN
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.